Clearpoint Neuro Stock Last Dividend Paid

CLPT Stock

USD 10.41 0.12 1.14%

Clearpoint Neuro's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Clearpoint Stock price.

Short Long Term Debt Total Total Assets

Build AI portfolio with Clearpoint Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Clearpoint Neuro Company Last Dividend Paid Analysis

Clearpoint Neuro's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis

Clearpoint Last Dividend Paid Driver Correlations

Understanding the fundamental principles of building solid financial models for Clearpoint Neuro is extremely important. It helps to project a fair market value of Clearpoint Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Clearpoint Neuro's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Clearpoint Neuro's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Clearpoint Neuro's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Intangible Assets	Long Term Debt	Long Term Debt Total	Capital Surpluse	Property Plant Equipment	Net Tangible Assets	Net Invested Capital	Short Long Term Debt	Net Working Capital	Capital Stock	Deferred Long Term Liab
Total Assets		0.92	0.14	-0.87	0.21	-0.55	0.66	0.26	1.0	-0.47	-0.14	-0.04	0.63	0.63	0.89	0.76	0.87	0.96	-0.15	0.96	0.88	0.7
Total Stockholder Equity	0.92		0.02	-0.93	0.17	-0.69	0.73	-0.07	0.92	-0.59	-0.13	-0.22	0.46	0.45	0.86	0.61	0.91	0.87	-0.36	0.88	0.85	0.68
Current Deferred Revenue	0.14	0.02		-0.09	0.09	0.5	0.46	0.56	0.11	-0.12	-0.36	0.68	0.14	0.13	0.36	0.09	0.41	0.18	-0.41	0.18	0.44	0.5
Net Debt	-0.87	-0.93	-0.09		-0.2	0.47	-0.62	0.04	-0.88	0.44	0.15	0.22	-0.32	-0.32	-0.78	-0.59	-0.89	-0.87	0.32	-0.87	-0.77	-0.55
Retained Earnings	0.21	0.17	0.09	-0.2		-0.15	0.23	0.16	0.22	0.06	-0.19	-0.41	0.15	0.15	0.22	0.16	0.19	0.15	-0.09	0.16	0.2	0.15
Accounts Payable	-0.55	-0.69	0.5	0.47	-0.15		-0.43	0.36	-0.55	0.53	-0.13	0.57	-0.39	-0.39	-0.46	-0.42	-0.39	-0.4	0.08	-0.42	-0.42	-0.29
Net Receivables	0.66	0.73	0.46	-0.62	0.23	-0.43		0.15	0.63	-0.57	-0.16	-0.01	0.55	0.54	0.83	0.49	0.88	0.6	-0.74	0.6	0.9	0.86
Total Liab	0.26	-0.07	0.56	0.04	0.16	0.36	0.15		0.24	0.2	-0.09	0.52	0.57	0.58	0.15	0.48	0.16	0.36	0.0	0.34	0.27	0.18
Total Current Assets	1.0	0.92	0.11	-0.88	0.22	-0.55	0.63	0.24		-0.46	-0.15	-0.06	0.61	0.61	0.88	0.75	0.86	0.96	-0.14	0.97	0.86	0.67
Short Term Debt	-0.47	-0.59	-0.12	0.44	0.06	0.53	-0.57	0.2	-0.46		0.61	0.13	-0.46	-0.46	-0.62	-0.48	-0.51	-0.36	0.29	-0.39	-0.58	-0.43
Common Stock	-0.14	-0.13	-0.36	0.15	-0.19	-0.13	-0.16	-0.09	-0.15	0.61		-0.13	-0.2	-0.2	-0.28	-0.21	-0.2	-0.14	0.06	-0.16	-0.21	-0.12
Intangible Assets	-0.04	-0.22	0.68	0.22	-0.41	0.57	-0.01	0.52	-0.06	0.13	-0.13		-0.06	-0.06	0.03	-0.19	0.05	0.06	0.06	0.04	0.08	0.25
Long Term Debt	0.63	0.46	0.14	-0.32	0.15	-0.39	0.55	0.57	0.61	-0.46	-0.2	-0.06		1.0	0.57	0.88	0.45	0.58	-0.2	0.58	0.62	0.44
Long Term Debt Total	0.63	0.45	0.13	-0.32	0.15	-0.39	0.54	0.58	0.61	-0.46	-0.2	-0.06	1.0		0.57	0.88	0.44	0.58	-0.18	0.58	0.62	0.43
Capital Surpluse	0.89	0.86	0.36	-0.78	0.22	-0.46	0.83	0.15	0.88	-0.62	-0.28	0.03	0.57	0.57		0.6	0.91	0.79	-0.33	0.79	0.96	0.9
Property Plant Equipment	0.76	0.61	0.09	-0.59	0.16	-0.42	0.49	0.48	0.75	-0.48	-0.21	-0.19	0.88	0.88	0.6		0.57	0.74	-0.16	0.75	0.66	0.32
Net Tangible Assets	0.87	0.91	0.41	-0.89	0.19	-0.39	0.88	0.16	0.86	-0.51	-0.2	0.05	0.45	0.44	0.91	0.57		0.86	-0.55	0.86	0.94	0.82
Net Invested Capital	0.96	0.87	0.18	-0.87	0.15	-0.4	0.6	0.36	0.96	-0.36	-0.14	0.06	0.58	0.58	0.79	0.74	0.86		-0.19	1.0	0.82	0.6
Short Long Term Debt	-0.15	-0.36	-0.41	0.32	-0.09	0.08	-0.74	0.0	-0.14	0.29	0.06	0.06	-0.2	-0.18	-0.33	-0.16	-0.55	-0.19		-0.19	-0.48	-0.47
Net Working Capital	0.96	0.88	0.18	-0.87	0.16	-0.42	0.6	0.34	0.97	-0.39	-0.16	0.04	0.58	0.58	0.79	0.75	0.86	1.0	-0.19		0.82	0.59
Capital Stock	0.88	0.85	0.44	-0.77	0.2	-0.42	0.9	0.27	0.86	-0.58	-0.21	0.08	0.62	0.62	0.96	0.66	0.94	0.82	-0.48	0.82		0.9
Deferred Long Term Liab	0.7	0.68	0.5	-0.55	0.15	-0.29	0.86	0.18	0.67	-0.43	-0.12	0.25	0.44	0.43	0.9	0.32	0.82	0.6	-0.47	0.59	0.9

Click cells to compare fundamentals

Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.

Competition

Predict Clearpoint Neuro

Clearpoint Dividends Paid

Dividends Paid

254,400

At this time, Clearpoint Neuro's Dividends Paid is comparatively stable compared to the past year.

Based on the recorded statements, Clearpoint Neuro has a Last Dividend Paid of 0.0. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Clearpoint Neuro Current Valuation Drivers

We derive many important indicators used in calculating different scores of Clearpoint Neuro from analyzing Clearpoint Neuro's financial statements. These drivers represent accounts that assess Clearpoint Neuro's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Clearpoint Neuro's important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	251.9M	232.6M	204.8M	167.1M	415.7M	436.5M
Enterprise Value	256.0M	190.8M	189.2M	157.9M	399.1M	419.1M

Clearpoint Neuro ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Clearpoint Neuro's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Clearpoint Neuro's managers, analysts, and investors.

Environmental

Governance

Social

Clearpoint Fundamentals

	Return On Equity	-0.76
	Return On Asset	-0.32
	Profit Margin	(0.65) %
	Operating Margin	(0.73) %
	Current Valuation	288.68 M
	Shares Outstanding	28.27 M
	Shares Owned By Insiders	8.22 %
	Shares Owned By Institutions	35.19 %
	Number Of Shares Shorted	2.07 M
	Price To Earning	(3.36) X
	Price To Book	14.13 X
	Price To Sales	9.24 X
	Revenue	31.39 M
	Gross Profit	19.73 M
	EBITDA	(17.84 M)
	Net Income	(18.91 M)
	Cash And Equivalents	45.14 M
	Cash Per Share	1.84 X
	Total Debt	3.57 M
	Debt To Equity	0.28 %
	Current Ratio	10.33 X
	Book Value Per Share	0.71 X
	Cash Flow From Operations	(8.95 M)
	Short Ratio	3.76 X
	Earnings Per Share	(0.76) X
	Price To Earnings To Growth	(0.46) X
	Target Price	29.0
	Number Of Employees	115
	Beta	0.85
	Market Capitalization	297.93 M
	Total Asset	39.19 M
	Retained Earnings	(191.37 M)
	Working Capital	23.01 M
	Current Asset	8.1 M
	Current Liabilities	1.85 M
	Net Asset	39.19 M

About Clearpoint Neuro Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Clearpoint Neuro's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearpoint Neuro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearpoint Neuro based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC